Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 166
Gastrointestinal Drugs 148
Immune Disorders Drugs 129
Central Nervous System Drugs 128
Biopharmaceuticals 88
Pharmaceuticals 84
Hematological Drugs 79
Vaccines 77
Clinical Trials 67
Drug Discovery 63
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 53
Leukemia Drugs 53
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Liver and Kidney Disorders Drugs 32
Infusions and Injectables 31
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 24
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 18
Pharmaceutical Manufacturing 17
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Transdermal and Transmucosal Drug Delivery 6
Thyroid Cancer Drugs 6
Uterine Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Cough and Cold Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



285 reviews

1,651 Results (Page 8 of 83)
- Relevance
  Sort by

Anaplastic Thyroid Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1112EUR$1,250USD£955GBP

Hereditary Angioedema (HAE) Therapeutics Market 2024-2028

 Report
July 2024
161 Pages
Global

From

€2225EUR$2,500USD£1,910GBP

Skin Cancer Drugs Market - Global Strategic Business Report

 Report
September 2026
483 Pages
Global

From

€5206EUR$5,850USD£4,469GBP

Chemotherapy Induced Peripheral Neuropathy Treatment Market - Global Forecast 2026-2032

 Report
January 2026
181 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Sleep Apnoea Syndrome - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1335EUR$1,500USD£1,146GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Schizophrenia Drugs Market Report by Treatment, Therapeutic Class, Distribution Channel, Country and Company Analysis 2026-2034

 Report
June 2026
200 Pages
Global

From

€2661EUR$2,990USD£2,284GBP

Endometriosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
161 Pages
Global

From

€1780EUR$2,000USD£1,528GBP

Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026

 Report
December 2020
200 Pages
Global

€3960EUR$4,450USD£3,399GBP

Schizophrenia Therapeutics Market - Global Forecast 2026-2032

 Report
August 2026
190 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Chemotherapy Induced Peripheral Neuropathy Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3995EUR$4,490USD£3,430GBP

Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis, and Competitive Landscape - Analysis and Forecast, 2022-2032

 Report
June 2022
207 Pages
Global

From

€2336EUR$2,625USD£2,005GBP

€4672EUR$5,250USD£4,010GBP

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026

 Report
March 2026
450 Pages
Global

From

€3555EUR$3,995USD£3,052GBP

Collaboration Deals in Pharmaceuticals 2020-2026

 Report
March 2026
850 Pages
Global

From

€4445EUR$4,995USD£3,816GBP

Waldenstrom's Macroglobulinemia (WM) Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
110 Pages
Global

From

€4227EUR$4,750USD£3,628GBP

Nivolumab Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3995EUR$4,490USD£3,430GBP

Intravenous Immunoglobulin Market by Application and Type: Global Opportunity Analysis and Industry Forecast, 2027

 Report
July 2023
179 Pages
Global

From

€4004EUR$4,500USD£3,437GBP

T-cell lymphoma Market - Global Forecast 2026-2032

 Report
August 2026
199 Pages
Global

From

€3155EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Castleman Disease Treatment Market - Global Forecast 2026-2032

 Report
August 2026
181 Pages
Global

From

€3154EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Lymphoma Therapeutics Market - Global Forecast 2026-2032

 Report
August 2026
187 Pages
Global

From

€3154EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

Non-Hodgkin Lymphoma Treatment Market - Global Forecast 2026-2032

 Report
August 2026
182 Pages
Global

From

€3154EUR$3,545USD£2,708GBP

€3505EUR$3,939USD£3,009GBP

1,651 Results (Page 8 of 83)
- 1
- 6
- 7
- 8
- 9
- 10

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.